David A. Socks is Director at Phathom Pharmaceuticals, Inc. (PHAT). They have made 11 open-market trades across 1 company since 2009, most recently 2024-05-23.
CIK 0001378847
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PHAT | SELL | 2021-10-07 | 2021-10-08 | $32.57 | $1.2M | -7.4% | -29.3% | -45.8% |
| PHAT | SELL | 2021-09-21 | 2021-09-23 | $32.70 | $1.0M | -1.7% | -6.9% | -39.7% |
| PHAT | SELL | 2021-08-16 | 2021-08-18 | $31.25 | $1.1M | +12.6% | +9.5% | -30.9% |
| PHAT | SELL | 2021-06-28 | 2021-06-29 | $34.06 | $2.2M | +2.8% | -6.0% | -3.2% |
| PHAT | SELL | 2021-05-19 | 2021-05-21 | $32.61 | $2.6M | -6.3% | -0.5% | -13.0% |
| PHAT | SELL | 2021-04-05 | 2021-04-07 | $36.58 | $2.9M | -7.3% | -10.5% | -10.6% |
| PHAT | SELL | 2021-03-10 | 2021-03-12 | $47.57 | $5.1M | -10.2% | -15.5% | -22.3% |
| PHAT | SELL | 2021-02-19 | 2021-02-23 | $46.52 | $6.5M | +2.2% | -8.1% | -20.0% |
| PHAT | SELL | 2021-01-11 | 2021-01-13 | $35.70 | $2.9M | +8.7% | +22.1% | +6.8% |
| PHAT | SELL | 2020-12-16 | 2020-12-18 | $43.33 | $6.7M | -12.6% | +1.4% | +11.1% |
| PHAT | SELL | 2020-11-09 | 2020-11-12 | $41.31 | $2.5M | +12.4% | +16.6% | +15.0% |
| CADX | SELL · 10b5-1 | 2010-06-14 | 2010-06-15 | $7.05 | $71K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-05-10 | 2010-05-11 | $9.20 | $92K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-04-19 | 2010-04-20 | $10.00 | $50K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-04-12 | 2010-04-13 | $9.31 | $93K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-03-08 | 2010-03-09 | $9.30 | $93K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-02-08 | 2010-02-09 | $10.26 | $128K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-01-11 | 2010-01-12 | $10.06 | $126K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-12-17 | 2009-12-18 | $10.00 | $25K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-12-14 | 2009-12-16 | $9.34 | $93K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-11-09 | 2009-11-10 | $10.00 | $125K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-10-12 | 2009-10-13 | $11.60 | $145K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-09-14 | 2009-09-15 | $10.69 | $134K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-08-10 | 2009-08-12 | $10.98 | $137K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-07-13 | 2009-07-15 | $10.33 | $129K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.